secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2026-10-05T13:07:15+00:00
Accession:  0001388658-26-000083
Event type: m_and_a
Sentiment:  positive
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

iRhythm closes $237.5M cash acquisition of VitalConnect, adding MCT and multi-vitals monitoring
--------------------------------------------------------------------------------

- Purchase consideration was $237.5M in cash, subject to customary adjustments, plus up to 423,334 shares issued at closing, funded from iRhythm's balance sheet.
- iRhythm also provided $10.0M of working capital funding to VitalConnect between signing and closing.
- Transaction is expected to enhance iRhythm's revenue growth rate beginning in 2027 while preserving its previously communicated 15% adjusted EBITDA margin target for 2027.
- VitalConnect adds mobile cardiac telemetry, up to 30-day patient monitoring, four-in-one functionality, live look-in and monitoring of up to 11 physiological parameters.
- Updated 2026 guidance inclusive of VitalConnect will be given on iRhythm's Q3 earnings call November 5, 2026; CEO Quentin Blackford cited expansion into inpatient and hospital-to-home care.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865826000083/0001388658-26-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865826000083/irtc-20261005.htm
  HTML page:      https://secwatch.observer/filing/0001388658-26-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer